Cite
Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
MLA
Petrice M. Cogswell, et al. “Associations of Quantitative Susceptibility Mapping with Alzheimer’s Disease Clinical and Imaging Markers.” NeuroImage, vol. 224, no. 117433-, Jan. 2021. EBSCOhost, https://doi.org/10.1016/j.neuroimage.2020.117433.
APA
Petrice M. Cogswell, Heather J. Wiste, Matthew L. Senjem, Jeffrey L. Gunter, Stephen D. Weigand, Christopher G. Schwarz, Arvin Arani, Terry M. Therneau, Val J. Lowe, David S. Knopman, Hugo Botha, Jonathan Graff-Radford, David T. Jones, Kejal Kantarci, Prashanthi Vemuri, Bradley F Boeve, Michelle M. Mielke, Ronald C. Petersen, & Clifford R. Jack, J. (2021). Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers. NeuroImage, 224(117433-). https://doi.org/10.1016/j.neuroimage.2020.117433
Chicago
Petrice M. Cogswell, Heather J. Wiste, Matthew L. Senjem, Jeffrey L. Gunter, Stephen D. Weigand, Christopher G. Schwarz, Arvin Arani, et al. 2021. “Associations of Quantitative Susceptibility Mapping with Alzheimer’s Disease Clinical and Imaging Markers.” NeuroImage 224 (117433-). doi:10.1016/j.neuroimage.2020.117433.